MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+69.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+69.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$202.86M+79.9%
2024$112.77M+254.6%
2023$31.80M-24.4%
2022$42.05M+18.4%
2021$35.52M-
2020$0.00-